Sustainability and Transformation Plans (STPs) – Where Next? A Roundtable Discussion
The session will explore the role of STPs in meeting the challenges faced by England’s health and care system, and how they relate to pre-existing devo-health deals.
- Dr Amanda Doyle OBE, Lead for Lancashire and South Cumbria STP
- Michael MacDonnell, Director of Strategy at NHS England
- Rob Webster, Lead for West Yorkshire STP
- Stephen Dorrell, Former Secretary of State for Health and Chairman of the NHS Confederation
Chair: Tom Kibasi, Director of IPPR
The session will explore the role of STPs in meeting the challenges faced by England’s health and care system, and how they relate to pre-existing devo-health deals. This will take place on Wednesday 15th March, from 10.00am to 12.00pm, at IPPR (14 Buckingham Street, London WC2N 6DF).
Limited resources, demographic change and increasingly complex health needs are producing a significant funding gap across health and social care. Projections indicate that this gap will grow over the coming years, to the extent that the NHS could be facing a financial shortfall of £20bn by 2020-21 if no action is taken.
NHS planning guidance published in December 2015 announced STPs in response to these challenges. STPs are partnerships between all statutory bodies involved in health and social care in each STP ‘footprint’ area. These organisations include NHS trusts, CCGs and local authorities. There are 44 ‘footprints’ across England with each STP required to address ‘national challenges’ including gaps in: health and wellbeing; quality of care; and efficiency and the financial challenge.
Some proponents of health devolution argue that STPs are an appropriate response to meeting local needs by moving towards place-based models of care. However, others are more skeptical and fear that they will be used to justify service closures rather than bring much-needed improvements to local provision.
At this roundtable, we will consider how STPs should be used to shape healthcare in England. We are inviting leading health thinkers, professionals and policy-makers to participate in a discussion which will focus on the following questions: